Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Immunohistochemistry on the primary tumor for PSMA-expression might predict the detection of biochemical recurrence with 68Ga-PSMA-11-PET.

Irene Burger, Ferraro Daniela, Jan Ruschoff, Michael Messerli, Urs Jacob Muehlematter, Benedikt Kranzbuehler, Lars Husmann, Thomas Hermanns, Daniel Eberli and Niels Rupp
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1266;
Irene Burger
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferraro Daniela
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Ruschoff
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Messerli
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urs Jacob Muehlematter
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedikt Kranzbuehler
2Department of Urology University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Husmann
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Hermanns
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Eberli
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niels Rupp
1University Hospital Zurich Zurich Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 1266

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Irene Burger1,
  2. Ferraro Daniela1,
  3. Jan Ruschoff1,
  4. Michael Messerli1,
  5. Urs Jacob Muehlematter1,
  6. Benedikt Kranzbuehler2,
  7. Lars Husmann1,
  8. Thomas Hermanns1,
  9. Daniel Eberli1 and
  10. Niels Rupp1
  1. 1University Hospital Zurich Zurich Switzerland
  2. 2Department of Urology University Hospital Zurich Zurich Switzerland

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 20201600
Jun 20202300
Jul 20201800
Aug 20202100
Sep 20202000
Oct 20202300
Nov 20202200
Dec 20203600
Jan 20211400
Feb 20212400
Mar 20214100
Apr 20212800
May 20212800
Jun 20211600
Jul 20211000
Aug 20211300
Sep 2021500
Oct 20211300
Nov 2021700
Dec 20211300
Jan 2022900
Feb 20221000
Mar 2022800
Apr 2022900
May 2022300
Jun 2022400
Jul 2022100
Aug 2022300
Sep 2022400
Oct 2022300
Nov 2022200
Dec 2022300
Jan 2023200
Feb 2023300
Mar 2023500
Apr 2023600
May 2023700
Jun 2023200
Jul 2023300
Aug 2023500
Sep 2023500
Oct 2023700
Nov 20231300
Dec 2023900
Jan 2024800
Feb 2024400
Mar 20241000
Apr 2024200
May 2024800
Jun 2024400
Jul 20241300
Aug 2024900
Sep 2024700
Oct 2024400
Nov 20241000
Dec 2024500
Jan 2025200
Feb 2025800
Mar 2025800
Apr 2025900
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Immunohistochemistry on the primary tumor for PSMA-expression might predict the detection of biochemical recurrence with 68Ga-PSMA-11-PET.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Immunohistochemistry on the primary tumor for PSMA-expression might predict the detection of biochemical recurrence with 68Ga-PSMA-11-PET.
Irene Burger, Ferraro Daniela, Jan Ruschoff, Michael Messerli, Urs Jacob Muehlematter, Benedikt Kranzbuehler, Lars Husmann, Thomas Hermanns, Daniel Eberli, Niels Rupp
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1266;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Immunohistochemistry on the primary tumor for PSMA-expression might predict the detection of biochemical recurrence with 68Ga-PSMA-11-PET.
Irene Burger, Ferraro Daniela, Jan Ruschoff, Michael Messerli, Urs Jacob Muehlematter, Benedikt Kranzbuehler, Lars Husmann, Thomas Hermanns, Daniel Eberli, Niels Rupp
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1266;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of Manual and Computer-Generated Methods for Segmentation of the Aorta in Lymphoma Patients from PET/CT Imaging
  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
Show more

GU - PSMA PET (Poster Session)

  • 68Ga-PSMA-PET/CT after a non-contributively 18F-Choline PET/CT in patients in biochemical relapse of prostate cancer
  • A phase II, open‐label study to assess safety and clinical utility of 68Ga‐THP‐PSMA PET/CT in patients with high‐risk primary prostate cancer or biochemical recurrence after radical treatment
  • Does the Injected Mass influence the Biodistribution of F-18-rhPSMA-7.3 on Positron Emission Tomography in Prostate Cancer Patients?
Show more GU - PSMA PET (Poster Session)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire